|
Volumn 23, Issue 5, 2005, Pages 552-554
|
Bringing amyloid into focus
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BRAIN;
DEPOSITS;
FLUORESCENCE;
MEDICAL IMAGING;
AMYLOID DEPOSITS;
NEAR-INFRARED FLUORESCENCE IMAGING;
ORGANIC COMPOUNDS;
AMYLOID BETA PROTEIN;
DIAGNOSTIC AGENT;
FLUORESCENT DYE;
OXAZINE DERIVATIVE;
ALZHEIMER DISEASE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
BLOOD BRAIN BARRIER;
COST EFFECTIVENESS ANALYSIS;
MOUSE;
NEAR INFRARED SPECTROSCOPY;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
SENSITIVITY AND SPECIFICITY;
SHORT SURVEY;
TREATMENT OUTCOME;
ANIMAL;
BRAIN;
DISEASE COURSE;
FEMALE;
FLUORESCENCE MICROSCOPY;
INFRARED SPECTROPHOTOMETRY;
METABOLISM;
METHODOLOGY;
NOTE;
PATHOLOGY;
TISSUE DISTRIBUTION;
TRANSGENIC MOUSE;
ULTRASTRUCTURE;
ANIMALIA;
ALZHEIMER DISEASE;
AMYLOID BETA-PROTEIN;
ANIMALS;
BLOOD-BRAIN BARRIER;
BRAIN;
DISEASE PROGRESSION;
FEMALE;
FLUORESCENT DYES;
MICE;
MICE, TRANSGENIC;
MICROSCOPY, FLUORESCENCE;
OXAZINES;
SPECTROPHOTOMETRY, INFRARED;
TISSUE DISTRIBUTION;
|
EID: 22844438906
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0505-552 Document Type: Short Survey |
Times cited : (11)
|
References (14)
|